Literature DB >> 11453956

Increased insulin sensitivity in young, growth hormone deficient children.

S Husbands1, K K Ong, J Gilbert, J A Wass, D B Dunger.   

Abstract

OBJECTIVE: Although growth hormone (GH) has well documented insulin antagonistic effects, GH deficient adults often demonstrate insulin resistance. In young GH deficient children, increased susceptibility to hypoglycaemia might indicate increased insulin sensitivity; however, this has not been documented. We therefore determined insulin sensitivity in GH deficient and GH sufficient children. DESIGN AND PATIENTS: Prospective study of children undergoing insulin tolerance tests for clinical investigation of GH or cortisol secretion at a regional Paediatric Endocrine/Growth Clinic between October 1986 and December 1997. Ninety-one tests were performed in children with GH deficiency and 142 tests in children with normal GH response to insulin (peak GH > or = 20 IU/l). MEASUREMENTS: The standard insulin tolerance test was modified to permit frequent measurements of glucose (0, 5, 10, 15, 20, 30, 45, 60 and 90 minutes). Rate of log glucose disappearance in the first 15 minutes was calculated as a direct measure of insulin sensitivity.
RESULTS: GH deficient children were more insulin sensitive than GH sufficient children (P = 0.004) and had lower glucose nadirs post-insulin (P = 0.005). Subgroup analysis revealed that these differences were greater in younger (< 12 years old) or pre/early pubertal children. In 14 prepubertal children, exogenous sex steroid priming resulted in lower insulin sensitivity (P < 0.05) compared to nonprimed tests.
CONCLUSIONS: Young GH deficient children were more insulin sensitive than children with normal GH secretion. This difference attenuated with age and puberty, possibly secondary to pubertal sex steroids; however, insulin resistance as reported in GH deficient adults, was not observed in adolescents.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11453956     DOI: 10.1046/j.1365-2265.2001.01298.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  7 in total

1.  Loss of growth hormone-mediated signal transducer and activator of transcription 5 (STAT5) signaling in mice results in insulin sensitivity with obesity.

Authors:  Yash Chhabra; Caroline N Nelson; Monika Plescher; Johanna L Barclay; Aaron G Smith; Sof Andrikopoulos; Salvatore Mangiafico; David J Waxman; Andrew J Brooks; Michael J Waters
Journal:  FASEB J       Date:  2019-02-19       Impact factor: 5.191

2.  Dwarfism and insulin resistance in male offspring caused by α1-adrenergic antagonism during pregnancy.

Authors:  Rebecca Oelkrug; Beate Herrmann; Cathleen Geissler; Lisbeth Harder; Christiane Koch; Hendrik Lehnert; Henrik Oster; Henriette Kirchner; Jens Mittag
Journal:  Mol Metab       Date:  2017-07-01       Impact factor: 7.422

Review 3.  Childhood-onset growth hormone deficiency and the transition to adulthood: current perspective.

Authors:  M Ahmid; S F Ahmed; M G Shaikh
Journal:  Ther Clin Risk Manag       Date:  2018-11-23       Impact factor: 2.423

Review 4.  Glucose Metabolism in Children With Growth Hormone Deficiency.

Authors:  Alessandro Ciresi; Carla Giordano
Journal:  Front Endocrinol (Lausanne)       Date:  2018-06-11       Impact factor: 5.555

5.  Association between triglyceride glucose index and peak growth hormone in children with short stature.

Authors:  Qianqian Zhao; Yuntian Chu; Hui Pan; Mei Zhang; Bo Ban
Journal:  Sci Rep       Date:  2021-01-21       Impact factor: 4.379

6.  Evaluation of left ventricular mass and function, lipid profile, and insulin resistance in Egyptian children with growth hormone deficiency: A single-center prospective case-control study.

Authors:  Kotb Abbass Metwalley; Hekma Saad Farghaly; Heba Ahmed Abd El-Hafeez
Journal:  Indian J Endocrinol Metab       Date:  2013-09

7.  Short Stature Diagnosis and Referral.

Authors:  Mohamad Maghnie; José I Labarta; Ekaterina Koledova; Tilman R Rohrer
Journal:  Front Endocrinol (Lausanne)       Date:  2018-01-11       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.